{"id":"W4387826951","doi":"10.1016/j.annonc.2023.09.1027","title":"2378P Efficacy and safety outcomes with pembrolizumab (pembro) rechallenge for patients (pts) with advanced/metastatic urothelial cancer (UC) who responded to first-course treatment","year":2023,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Urothelial cancer; Pembrolizumab; Cancer; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003457498,0.0001569797,0.0005532138,0.0001553149,0.0002211746,0.0004115981,0.0001484198,0.0003134078,0.001948217],"category_scores_gemma":[0.0008774348,0.00007004983,0.0007733657,0.0001850362,0.0001600787,0.0003520117,0.0001399663,0.0008297877,0.000346515],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004418769,"about_ca_system_score_gemma":0.0003237592,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007670088,"about_ca_topic_score_gemma":0.001295331,"domain_scores_codex":[0.9998518,0.00004085063,0.00001047594,0.00002729597,0.00002655067,0.0000429299],"domain_scores_gemma":[0.999731,0.00007452432,0.00007353185,0.00001460334,0.00002655501,0.00007978291],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.2561151,0.006619841,0.2303759,0.0009829046,0.002826857,0.001275627,0.000302657,0.00309332,0.02242954,0.0003213191,0.007421082,0.4682356],"study_design_scores_gemma":[0.02646584,0.1617744,0.7785228,0.0002202212,0.00314804,0.002712416,0.0002852349,0.004474211,0.008114137,0.0005719158,0.01365234,0.00005843273],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947399,0.002239447,0.00009758784,0.0002814667,0.00004867381,0.00006249709,0.0004219524,0.00002006925,0.002088496],"genre_scores_gemma":[0.9985406,0.0003537231,0.0000502293,0.0001287863,0.00003371284,0.00003152979,0.0003455009,0.000002353723,0.0005136495],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001948217,"threshold_uncertainty_score":0.00651741,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08085293338280829,"score_gpt":0.4097118803035344,"score_spread":0.3288589469207261,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}